Get the Stockscreener App
4.25
1,407%
3.968
Pre-market:
4.29
0.04
+0.94%
Glucotrack Inc stock is traded at $4.25, with a volume of 153.01K.
It is up +1,407% in the last 24 hours and up +790.99% over the past month.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
See More
Previous Close:
$0.282
Open:
$4.2
24h Volume:
153.01K
Relative Volume:
0.02
Market Cap:
$44.96M
Revenue:
-
Net Income/Loss:
$-16.89M
P/E Ratio:
-0.2035
EPS:
-20.8847
Net Cash Flow:
$-16.44M
1W Performance:
+1,179%
1M Performance:
+790.99%
6M Performance:
+174.19%
1Y Performance:
+0.71%
1-Day Range:
$4.00
$4.36
1-Week Range:
$0.279
$4.36
52-Week Range:
$0.25
$14.14
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
4.25 | 3.61M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
376.86 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.11 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.06 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
240.10 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.03 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Glucotrack Inc Stock (GCTK) Latest News
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia - marketscreener.com
Form 8K GlucoTrack Inc For: 19 August By Investing.com - Investing.com Nigeria
Glucotrack shareholders approve director elections, reverse split, and warrant inducement - Investing.com
Glucotrack Shareholders Approve Up to 1-for-30 Reverse Stock Split - Minichart
Glucotrack (NASDAQ: GCTK) investors back reverse split, warrant deal - Stock Titan
GlucoTrack Stock Short Interest Rises to 33.15% - Quiver Quantitative
GlucoTrack, Inc. (GCTK) Latest Stock News & Headlines - Yahoo Finance
Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances - Yahoo Finance
Glucotrack regains Nasdaq compliance on equity requirement By Investing.com - Investing.com South Africa
Glucotrack regains Nasdaq compliance on equity requirement - Investing.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Business Wire
Glucotrack Company Profile & Introduction - Moomoo
Glucotrack Inc. (GCTK) narrows loss, warns on going concern and closes Lokahi deal - Stock Titan
GlucoTrack, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GlucoTrack Amends Equity Financing and Issues Commitment Shares - TipRanks
GlucoTrack Inc (GCTK) Stock News Today - tradingkey.com
GlucoTrack Secures New Financing to Support Growth - The Globe and Mail
Glucotrack Raises $5.5M as It Settles Into Its New Identity as an AI-Driven Biopharma Platform - biobuzz.io
E.F. Hutton Advises on $5.5 Million Financing for Glucotrack Subsidiary Lōkahi Therapeutics - citybiz
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack - The Manila Times
Glucotrack Secures $5.5 Million Financing With Premium Equity and Institutional Investment to Boost Growth - Minichart
Glucotrack Raises $5.5 Million Through Bridge Follow-On and Interim PIPE, Adds Registration Rights - TradingView
GlucoTrack, Inc. announced that it expects to receive $5.5 million in funding - marketscreener.com
Glucotrack Secures $5.5 Million Financing to Support Growth Strategy and Product Development - citybiz
Glucotrack Announces $5.5 Million Financing - marketscreener.com
Lōkahi Therapeutics Ai2 Futures Lab Changes How Biopharma Builds a Pipeline - 富途牛牛
Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline - marketscreener.com
GlucoTrack (GCTK) Shares Crash 40% to $0.47 as Critical Support Level ApproachesGap Up Stocks - vinanet.vn
GlucoTrack (GCTK) Stock Surges Over 70% After Hours: Why is it Moving? - webull.com
GlucoTrack surges as traders revisit Lōkahi merger and new financing package | GCTK Stock News - Quiver Quantitative
GlucoTrack, Inc. (NASDAQ:GCTK) surges 95% after LT-100 news, market eyes dilution impact - TechStock²
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Glucotrack (NASDAQ: GCTK) revises $900,000 debt-for-stock deal - Stock Titan
Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration - Yahoo Finance
GlucoTrack Restructures Debt Through Equity-Linked Note Exchange - theglobeandmail.com
GlucoTrack Creates $900,000 Partitioned Note, Enables Exchanges Into Stock at Market-Based Price - TradingView
Glucotrack (NASDAQ: GCTK) creates $900,000 exchangeable note for stock - Stock Titan
GlucoTrack Inc (GCTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GlucoTrack Inc (GCTK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GlucoTrack Inc (GCTK) Income Statement - TradingKey
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
GlucoTrack Inc (GCTK) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GlucoTrack Inc (NASDAQ: GCTK) Stock Price, News & Analysis - Kalkine
GCTK|GlucoTrack Inc|Price:0.297|Chg%:+0.006 - TradingKey
GCTK|GlucoTrack Inc|Price:0.294|Chg%:+0.003 - TradingKey
GlucoTrack Inc (GCTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GCTK|GlucoTrack Inc|Price:0.291|Chg%:-0.021 - TradingKey
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):